Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2014
09/04/2014WO2014134620A1 Acne solution
09/04/2014WO2014134586A2 Injectable long-acting local anesthetic semi-solid formulations and its compostions
09/04/2014WO2014134502A1 Topical compositions and methods of using the same
09/04/2014WO2014134477A1 Methods and systems for treating overweight individuals
09/04/2014WO2014134459A1 Operating an infusion pump system
09/04/2014WO2014134427A1 Controlling the bioavailability of active ingredients in topical formulations
09/04/2014WO2014134403A2 Aptamers that bind cd271
09/04/2014WO2014134394A1 Topical formulations of corticosteroids with enhanced bioavailability
09/04/2014WO2014134355A1 Drug combinations
09/04/2014WO2014134323A1 Implantable medical device for minimally-invasive insertion
09/04/2014WO2014134286A2 Cerium oxide nanoparticles accelerate the decay of peroxynitrite (onoo-)
09/04/2014WO2014134281A1 Biosynthesis of cannabinoids
09/04/2014WO2014134251A1 Pharmaceutical compositions
09/04/2014WO2014134225A2 Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance
09/04/2014WO2014134144A1 Mirna profiling compositions and methods of use
09/04/2014WO2014134132A1 Milk-derived microvesicle compositions and related methods
09/04/2014WO2014134070A1 Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
09/04/2014WO2014134049A1 Delayed release film coatings containing calcium silicate and substrates coated therewith
09/04/2014WO2014133547A1 Targeted nanoparticles
09/04/2014WO2014133401A1 High dose extended-release potassium citrate wax matrix tablet
09/04/2014WO2014133344A1 Transdermal absorption accelerator and uses thereof
09/04/2014WO2014133204A1 Heat releasing composition comprising shape anisotropic nanomaterial
09/04/2014WO2014133196A1 Suspension for oral administration comprising amorphous tolvaptan
09/04/2014WO2014132262A1 Peptide-based hydrogel particles and uses thereof
09/04/2014WO2014132226A1 Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof
09/04/2014WO2014132218A1 Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
09/04/2014WO2014132215A1 Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
09/04/2014WO2014132213A1 Compounds, processes for extracting them from kelp, compositions containing said compounds and use of said compositions
09/04/2014WO2014132205A1 Formulation comprising benzothiazolone compound
09/04/2014WO2014132179A1 Preparation of stabilized catalase enzymes with a surfactant
09/04/2014WO2014132163A1 Enhanced stability of novel liquid compositions
09/04/2014WO2014132134A1 A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
09/04/2014WO2014131825A1 Pharmaceutical formulations comprising quetiapine and escitalopram
09/04/2014WO2014131815A1 Peptides for use in the topical treatment of retinal neurodegenerative disesases, in particular in early stages of diabetic retinopathy and other retinal diseases in which neurodegeneration plays an essential role
09/04/2014WO2014131376A1 Electrospun nanofibers comprising pharmaceutically active agents
09/04/2014WO2014131122A1 Formulations of growth hormone releasing factor (grf) molecules with improved stability
09/04/2014WO2014080285A3 Pharmaceutical compositions having improved storage stability
09/04/2014WO2013186292A3 Method for obtaining a nano-capsule structure
09/04/2014WO2013090457A3 In vivo delivery of oligonucleotides
09/04/2014WO2013072937A3 Fast release solid oral compositions of entecavir
09/04/2014US20140249492 Transdermal patch incorporating active agent migration barrier layer
09/04/2014US20140249490 Methods for Prevention and/or Treatment of Capsular Contracture
09/04/2014US20140249351 Microparticles for selectively targeted hyperthermia
09/04/2014US20140249232 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
09/04/2014US20140249203 Nanoparticles stabilized with nitrophenylboronic acid compositions
09/04/2014US20140249191 Compositions for Controlling Vascularization in Ophthalmological and Dermatological Diseases
09/04/2014US20140249190 Fast Dissolving Tablet
09/04/2014US20140249184 Polymer-based surgically implatable haloperidol delivery systems and methods for their production and use
09/04/2014US20140249172 Intranasal naltrexone
09/04/2014US20140249171 Oral formulations and lipophilic salts of methylnaltrexone
09/04/2014US20140249158 Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same
09/04/2014US20140249125 High enhancer-loading polyacrylate formulation for transdermal applications
09/04/2014US20140249123 Extended release biodegradable ocular implants
09/04/2014US20140249112 Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
09/04/2014US20140249107 Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
09/04/2014US20140249102 Topical Applicator Composition and Process for Treatment of Radiologically Contaminated Dermal Injuries
09/04/2014US20140249092 Cyclosporin analog formulations
09/04/2014US20140249090 Peptides and pharmaceutical compositions for use in the treatment by nasal administration of patients suffering from anxiety and sleep disorders
09/04/2014US20140249081 Nanoparticle peptide compositions
09/04/2014US20140249077 Gel compositions
09/04/2014US20140249031 Micelle-coated crystalline particles
09/04/2014US20140248416 Apparatus and Method for Producing Controlled Dosage of Bioactive Agent
09/04/2014US20140248377 Multiple emulsion
09/04/2014US20140248367 Spray-dried pharmaceutical compositions comprising active agent nanoparticles
09/04/2014US20140248365 Nanoparticle peptide compositions
09/04/2014US20140248364 Divalent-metal coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
09/04/2014US20140248363 Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magnetite, production and uses thereof
09/04/2014US20140248362 Sustained-release preparation
09/04/2014US20140248360 Nanoparticle tumour vaccines
09/04/2014US20140248359 Novel formulation of diclofenac
09/04/2014US20140248354 Controlled release vaccines and methods for treating brucella diseases and disorders
09/04/2014US20140248353 Dosage form for insertion into the mouth
09/04/2014US20140248352 Chewable enteric coated aspirin tablets
09/04/2014US20140248350 Delayed release film coatings containing calcium silicate and substrates coated therewith
09/04/2014US20140248349 Process for the preparation of a solid, orally administrable pharmaceutical composition
09/04/2014US20140248348 Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases
09/04/2014US20140248347 Pharmaceutical compositions of n-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide
09/04/2014US20140248346 Misuse preventative, controlled release formulation
09/04/2014US20140248345 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with atorvastatin
09/04/2014US20140248344 Abuse resistant forms of extended release morphine, method of use and method of making
09/04/2014US20140248343 Abuse resistant forms of extended release morphine, method of use and method of making
09/04/2014US20140248341 Alcohol resistant enteric pharmaceutical compositions
09/04/2014US20140248340 Coated controlled release active agent carriers
09/04/2014US20140248338 Compositions and methods for silencing aldehyde dehydrogenase
09/04/2014US20140248337 Liposomal Vaccine Compositions Comprising a Polysaccharide Antigen and a Protein Adjuvant
09/04/2014US20140248335 Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof
09/04/2014US20140248332 Composition comprising an onion extract and liposomes
09/04/2014US20140248330 Device for transdermal administration of drugs including acrylic polymers
09/04/2014US20140248329 Therapeutic Implant
09/04/2014US20140248326 Encapsulated kidney tissue
09/04/2014US20140248320 Adjuvanted influenza b virus vaccines for pediatric priming
09/04/2014US20140248319 Multicomponent and biocompatible nanocomposite materials, methods of synthesizing same and applications of same
09/04/2014US20140248274 Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
09/04/2014US20140248270 Method for topical treatment of tar-responsive dermatological disorders
09/04/2014US20140248253 Compositions and methods for the treatment of cns injuries
09/04/2014US20140248223 Film compositions for delivery of actives
09/04/2014US20140248220 Foamable suspension gel
09/04/2014US20140248219 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
09/04/2014US20140248216 Drug delivery by carbon nanotube arrays
09/03/2014EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 2991